Abstract

Tramadol, a centrally acting analgesic, has attracted considerable attention in recent years because of its potential anxiolytic effects. This short article presents new data on the anxiolytic properties of tramadol. The review encompasses preclinical and clinical studies, examining the pharmacological mechanisms underlying Tramadol's anxiolytic effects, its efficacy, safety profile, tolerability, dependency potential compared with benzodiazepines, and the various formulations available. The evidence suggests that Tramadol shows promise as a potent anxiolytic agent; however, further research is warranted to establish its long-term effects, optimal dosing strategies, and safety considerations.